Moors & Cabot’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $217K | Sell |
2,617
-1,365
| -34% | -$113K | 0.01% | 773 |
|
|
2025
Q1 | $323K | Sell |
3,982
-340
| -8% | -$27.6K | 0.02% | 615 |
|
|
2024
Q4 | $389K | Sell |
4,322
-315
| -7% | -$28.4K | 0.02% | 578 |
|
|
2024
Q3 | $458K | Sell |
4,637
-2,300
| -33% | -$227K | 0.02% | 517 |
|
|
2024
Q2 | $643K | Buy |
6,937
+162
| +2% | +$15K | 0.03% | 406 |
|
|
2024
Q1 | $643K | Buy |
6,775
+3,305
| +95% | +$314K | 0.03% | 418 |
|
|
2023
Q4 | $310K | Sell |
3,470
-75
| -2% | -$6.7K | 0.02% | 618 |
|
|
2023
Q3 | $259K | Sell |
3,545
-199
| -5% | -$14.5K | 0.02% | 643 |
|
|
2023
Q2 | $312K | Sell |
3,744
-475
| -11% | -$39.5K | 0.02% | 601 |
|
|
2023
Q1 | $322K | Sell |
4,219
-50
| -1% | -$3.81K | 0.02% | 578 |
|
|
2022
Q4 | $354K | Buy |
4,269
+237
| +6% | +$19.7K | 0.02% | 522 |
|
|
2022
Q3 | $320K | Buy |
4,032
+87
| +2% | +$6.91K | 0.02% | 538 |
|
|
2022
Q2 | $293K | Sell |
3,945
-200
| -5% | -$14.9K | 0.02% | 571 |
|
|
2022
Q1 | $373K | Sell |
4,145
-825
| -17% | -$74.2K | 0.02% | 562 |
|
|
2021
Q4 | $556K | Sell |
4,970
-25
| -0.5% | -$2.8K | 0.03% | 431 |
|
|
2021
Q3 | $629K | Buy |
4,995
+152
| +3% | +$19.1K | 0.04% | 382 |
|
|
2021
Q2 | $656K | Buy |
4,843
+192
| +4% | +$26K | 0.05% | 352 |
|
|
2021
Q1 | $632K | Buy |
4,651
+183
| +4% | +$24.9K | 0.05% | 342 |
|
|
2020
Q4 | $630K | Buy |
4,468
+215
| +5% | +$30.3K | 0.05% | 310 |
|
|
2020
Q3 | $474K | Buy |
4,253
+470
| +12% | +$52.4K | 0.04% | 341 |
|
|
2020
Q2 | $421K | Buy |
3,783
+831
| +28% | +$92.5K | 0.04% | 352 |
|
|
2020
Q1 | $229K | Buy |
2,952
+81
| +3% | +$6.28K | 0.03% | 461 |
|
|
2019
Q4 | $275K | Buy |
+2,871
| New | +$275K | 0.03% | 483 |
|
|
2018
Q2 | – | Sell |
-4,991
| Closed | -$438K | – | 606 |
|
|
2018
Q1 | $438K | Buy |
4,991
+342
| +7% | +$30K | 0.06% | 357 |
|
|
2017
Q4 | $396K | Sell |
4,649
-59
| -1% | -$5.03K | 0.05% | 365 |
|
|
2017
Q3 | $407K | Buy |
4,708
+1,582
| +51% | +$137K | 0.06% | 345 |
|
|
2017
Q2 | $241K | Buy |
+3,126
| New | +$241K | 0.04% | 426 |
|
|
2017
Q1 | – | Sell |
-3,378
| Closed | -$200K | – | 557 |
|
|
2016
Q4 | $200K | Buy |
+3,378
| New | +$200K | 0.03% | 482 |
|
|
2016
Q1 | – | Sell |
-2,864
| Closed | -$200K | – | 547 |
|
|
2015
Q4 | $200K | Buy |
+2,864
| New | +$200K | 0.04% | 448 |
|
|
2015
Q2 | – | Sell |
-8,715
| Closed | -$655K | – | 543 |
|
|
2015
Q1 | $655K | Buy |
8,715
+3
| +0% | +$225 | 0.11% | 223 |
|
|
2014
Q4 | $543K | Sell |
8,712
-798
| -8% | -$49.7K | 0.09% | 248 |
|
|
2014
Q3 | $496K | Sell |
9,510
-435
| -4% | -$22.7K | 0.08% | 255 |
|
|
2014
Q2 | $509K | Buy |
+9,945
| New | +$509K | 0.09% | 258 |
|